These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33925951)

  • 21. Crosstalk between Human Microvascular Endothelial Cells and Tubular Epithelial Cells Modulates Pro-Inflammatory Responses Induced by Shiga Toxin Type 2 and Subtilase Cytotoxin.
    Álvarez RS; Jancic C; Garimano N; Sacerdoti F; Paton AW; Paton JC; Ibarra C; Amaral MM
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31703347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.
    Weinstein DL; Jackson MP; Perera LP; Holmes RK; O'Brien AD
    Infect Immun; 1989 Dec; 57(12):3743-50. PubMed ID: 2807546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The new allelic variant of the subtilase cytotoxin (subAB2) is common among Shiga toxin-producing Escherichia coli strains from large game animals and their meat and meat products.
    Sánchez S; Díaz-Sánchez S; Martínez R; Llorente MT; Herrera-León S; Vidal D
    Vet Microbiol; 2013 Oct; 166(3-4):645-9. PubMed ID: 23880308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shiga toxin 2 translocation across intestinal epithelium is linked to virulence of Shiga toxin-producing Escherichia coli in humans.
    Tran SL; Jenkins C; Livrelli V; Schüller S
    Microbiology (Reading); 2018 Apr; 164(4):509-516. PubMed ID: 29533744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of subtilase cytotoxin SubAB assembly.
    Le Nours J; Paton AW; Byres E; Troy S; Herdman BP; Johnson MD; Paton JC; Rossjohn J; Beddoe T
    J Biol Chem; 2013 Sep; 288(38):27505-27516. PubMed ID: 23921389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of protein disulfide isomerase in subtilase cytotoxin-induced cell death in HeLa cells.
    Tsutsuki H; Zhang T; Harada A; Rahman A; Ono K; Yahiro K; Niidome T; Sawa T
    Biochem Biophys Res Commun; 2020 May; 525(4):1068-1073. PubMed ID: 32184018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
    Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell.
    Cherubin P; Fidler D; Quiñones B; Teter K
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clathrin-dependent trafficking of subtilase cytotoxin, a novel AB5 toxin that targets the endoplasmic reticulum chaperone BiP.
    Chong DC; Paton JC; Thorpe CM; Paton AW
    Cell Microbiol; 2008 Mar; 10(3):795-806. PubMed ID: 18042253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
    Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
    Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of biologically active Shiga toxins in cell-free systems.
    Ramm F; Kaser D; König I; Fellendorf J; Wenzel D; Zemella A; Papatheodorou P; Barth H; Schmidt H
    Sci Rep; 2024 Mar; 14(1):6043. PubMed ID: 38472311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.
    Steil D; Schepers CL; Pohlentz G; Legros N; Runde J; Humpf HU; Karch H; Müthing J
    J Lipid Res; 2015 Dec; 56(12):2322-36. PubMed ID: 26464281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence characteristics of Shiga toxin-producing Escherichia coli from raw meats and clinical samples.
    Hoang Minh S; Kimura E; Hoang Minh D; Honjoh K; Miyamoto T
    Microbiol Immunol; 2015 Mar; 59(3):114-22. PubMed ID: 25644201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of Shiga toxin 2f, an immunologically unrelated subtype of Shiga toxin 2.
    Skinner C; McMahon S; Rasooly R; Carter JM; He X
    PLoS One; 2013; 8(3):e59760. PubMed ID: 23555772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
    Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
    Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of Escherichia coli subtilase cytotoxin and Shiga toxin 2 on chemokine and proinflammatory cytokine expression in human macrophage, colonic epithelial, and brain microvascular endothelial cell lines.
    Wang H; Rogers TJ; Paton JC; Paton AW
    Infect Immun; 2014 Sep; 82(9):3567-79. PubMed ID: 24914216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the newly identified subtilase cytotoxin-encoding gene (subAB2-2) among clinical Shiga toxin-producing Escherichia coli isolates.
    Son HM; Duc HM; Honjoh K; Miyamoto T
    Can J Microbiol; 2015 Dec; 61(12):990-4. PubMed ID: 26588258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtilase cytotoxin, produced by Shiga-toxigenic Escherichia coli, transiently inhibits protein synthesis of Vero cells via degradation of BiP and induces cell cycle arrest at G1 by downregulation of cyclin D1.
    Morinaga N; Yahiro K; Matsuura G; Moss J; Noda M
    Cell Microbiol; 2008 Apr; 10(4):921-9. PubMed ID: 18005237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.
    Luz D; Chen G; Maranhão AQ; Rocha LB; Sidhu S; Piazza RM
    PLoS One; 2015; 10(3):e0120481. PubMed ID: 25790467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining Mass Spectrometry, Surface Acoustic Wave Interaction Analysis, and Cell Viability Assays for Characterization of Shiga Toxin Subtypes of Pathogenic Escherichia coli Bacteria.
    Steil D; Pohlentz G; Legros N; Mormann M; Mellmann A; Karch H; Müthing J
    Anal Chem; 2018 Aug; 90(15):8989-8997. PubMed ID: 29939014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.